Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ppm decrease » _ decrease (Expand Search), pa decreased (Expand Search), 026 decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ppm decrease » _ decrease (Expand Search), pa decreased (Expand Search), 026 decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
941
Decreased dCAP-D3 levels result in spreading of repressive histone marks and an opening of the chromatin at a dCAP-D3 regulated gene cluster containing a retrotransposon.
Published 2013“…(B) qRT-PCR for transcript levels of genes surrounding <i>mdg1-1403</i> (as depicted in diagram in A) indicates that compared to control dsRNA treated cells, transcription is decreased in dCAP-D3 dsRNA treated cells prior to retrotransposon mobilization (day 4) and increases to almost normal levels on the day of retrotransposon mobilization (day 5). …”
-
942
APB5, but not APA5, decreases apoptosis in alveolar epithelial cells in lungs of BLM-treated mice.
Published 2018“…The administration of APA5 did not change the number of TUNEL-positive cells from that in BLM-treated mice, whereas that of APB5 significantly decreased them. …”
-
943
-
944
-
945
-
946
-
947
<i>Cdkl5</i> -/Y mice show an increased freezing time and a decreased distance traveled during the pretone period in the altered context.
Published 2018“…<i>Cdkl5</i> -/Y mice show a significantly decreased distance traveled in response to the first footshock (p = 0.0158) compared with control mice. …”
-
948
a-c: Proximal tibia (PT) EPO receptor (EPO-R) decreases in uremic rats, as shown by Western blot (Fig. 5a) and immunohistochemistry (Fig. 5b).
Published 2018“…Animals received a single bolus of IV rhEPO (25 U/kg) or saline, 5 minutes prior to sacrifice. …”
-
949
-
950
-
951
-
952
-
953
-
954
-
955
Gene expression of VEGF and vWF in EPC cultured on PLA, BG20 and BG40 over a period of 5 days.
Published 2013“…Generally, gene epression of VEGF declined over the time whereas gene expression of vWF increased during the observation period. The experiment was performed with 4 independent EPC preparations. ↑ = increased gene expression; ↓ = decreased gene expression.…”
-
956
-
957
The energy shift from Bragg's law predicted by Mosplate, including peak and profile shifts as used in the computation, with an estimated uncertainty of 1.5 ppm
Published 2013“…The peak energy of the titanium Kβ spectral profile is found to be 4931.966 ± 0.022 eV prior to instrumental broadening. This 4.5 ppm result decreases the uncertainty over the past literature by a factor of 2.6 and is 2.4 standard deviations from the previous standard. …”
-
958
Ethanol withdrawal (EW) decreases GluN2A subunit levels.
Published 2013“…<p>NMDA subunit protein levels measured by Western blot analysis: GluN2A levels (B) decrease during ethanol withdrawal, whereas the levels of GluN1 (A) and GluN2B (C) remain unaltered. …”
-
959
Image_2_Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease.JPEG
Published 2019“…At the cutoff value of 7.955 μg/mL serum ZAG, the sensitivity and specificity for differentiating patients with PCAD from controls were 50.5 and 78.0%, respectively. The combination of ZAG with other clinical variables including age, gender, BMI, SBP, FBG, TC, HDL-C, Cr, and Urea had significantly improved the diagnosis accuracy with a sensitivity of 82.6%, a specificity of 95.0%, and AUC of 0.957 (95% CI, 0.940–0.975, p < 0.05).…”
-
960
Image_1_Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease.JPEG
Published 2019“…At the cutoff value of 7.955 μg/mL serum ZAG, the sensitivity and specificity for differentiating patients with PCAD from controls were 50.5 and 78.0%, respectively. The combination of ZAG with other clinical variables including age, gender, BMI, SBP, FBG, TC, HDL-C, Cr, and Urea had significantly improved the diagnosis accuracy with a sensitivity of 82.6%, a specificity of 95.0%, and AUC of 0.957 (95% CI, 0.940–0.975, p < 0.05).…”